SMO ClinPlus CO.,LTD. (SHE:301257)

China flag China · Delayed Price · Currency is CNY
55.80
+1.35 (2.48%)
At close: Jul 20, 2026
Market Cap4.41B +53.2%
Revenue (ttm)860.07M +8.1%
Net Income114.23M +25.4%
EPS1.45 +27.2%
Shares Out 79.00M
PE Ratio38.51
Forward PEn/a
Dividend0.15 (0.27%)
Ex-Dividend DateJul 9, 2026
Volume8,636,627
Open51.29
Previous Close54.45
Day's Range51.05 - 57.57
52-Week Range35.12 - 85.00
Beta0.83
Analystsn/a
Price Targetn/a
Earnings DateAug 29, 2026

About SMO ClinPlus CO.,LTD.

SMO ClinPlus CO.,LTD. provides site management services in research and development in pharmaceuticals, medical devices, and health-related products in China. It offers clinical trial site management organization services to pharmaceuticals, medical devices, CRO companies, etc. The company offers preliminary modeling and preparation plans, trial site initiation, on-site execution, and project management services. SMO ClinPlus CO.,LTD. was founded in 2009 and is based in Huangpu, China. [Read more]

Sector Healthcare
Founded 2009
Employees 4,526
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301257
Full Company Profile

Financial Performance

In 2025, SMO ClinPlus CO.,LTD.'s revenue was 842.50 million, an increase of 4.82% compared to the previous year's 803.73 million. Earnings were 109.64 million, an increase of 3.01%.

Financial Statements